Skip to main content

Alert: Levonorgestrel ECP gets FDA approval

September 1, 1999

Alert: Levonorgestrel ECP gets FDA approval

As Contraceptive Technology Update went to press, the Women’s Capital Corporation of Seattle was preparing its new levonorgestrel-only emergency contraceptive pill (ECP), Plan B, for U.S. shipment. Interest in a dedicated progestin-only product has grown since a 1998 international study showed that the levonorgestrel pills are more effective and have fewer side effects than the current regimen using combined oral contraceptives for emergency contraception.

For more information on Plan B, as well as other emergency contraception news, turn to the story on p. 108.